NCT05617885 2026-02-27Neo-DAB: Darolutamide and Abemaciclib in Prostate CancerDana-Farber Cancer InstitutePhase 1 Active not recruiting9 enrolled
NCT06305598 2026-02-19Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate CancerRoswell Park Cancer InstitutePhase 1 Recruiting14 enrolled